AUROBINDO PHARMA LTD. (AUROPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 3,547.44 2,390.82 2,668.76 2,692.03 2,894.03 2,460.09 2,824.59 2,916.63 2,731.99 2,848.17 2,789.72 2,747.28
YOY Revenue Growth % 22.87% -14.21% -11.8% -21.57% -18.42% 2.9% 5.84% 8.34% -5.6% 15.78% -1.23% -5.81%
Other Income 288.17 94.88 67.08 331.13 122.97 65.32 122.66 54.26 113.98 83.77 159.52 130.15
Total Income 3,835.61 2,485.70 2,735.84 3,023.16 3,017.00 2,525.41 2,947.25 2,970.89 2,845.97 2,931.94 2,949.24 2,877.43
Total Expenses + 3,101.36 1,969.16 2,134.93 2,115.01 2,115.33 1,983.12 2,118.80 2,245.79 2,290.45 2,181.85 2,193.96 2,078.15
Cost of Materials Consumed 2,057.46 1,375.26 1,518.33 1,465.93 1,401.56 1,318.18 1,424.74 1,506.59 1,360.70 1,340.01 1,244.16 1,402.55
Employee Benefit Expense 406.77 236.06 247.51 248.08 248.91 259.33 265.48 265.15 273.11 282.97 294.37 291.10
Other Expenses 637.13 357.84 369.09 401.00 464.86 405.61 428.58 474.05 424.84 375.99 403.07 379.99
Operating Profit 446.08 421.66 533.83 577.02 778.70 476.97 705.79 670.84 441.54 666.32 595.76 669.13
OPM % 12.6% 17.6% 20% 21.4% 26.9% 19.4% 25% 23% 16.2% 23.4% 21.4% 24.4%
Profit Before Tax + 816.03 426.04 509.78 687.22 779.88 446.24 723.75 632.94 555.52 750.09 755.28 781.90
Tax Expense 171.23 90.09 94.04 63.44 201.21 117.20 186.22 160.89 147.35 190.96 173.91 199.83
Tax % 21% 21.1% 18.4% 9.2% 25.8% 26.3% 25.7% 25.4% 26.5% 25.5% 23% 25.6%
Profit After Tax 644.80 335.95 415.74 623.78 578.67 329.04 537.53 472.05 408.17 559.13 581.37 582.07
EPS (Basic) 11.00 5.74 7.10 10.65 9.88 5.62 9.21 8.13 7.03 9.63 10.01 10.02

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Revenue from Operations 10,933.30 10,645.64 12,792.28 11,287.14 15,823.68 13,266.48 10,303.15
YOY Revenue Growth % 2.7% -16.78% 13.33% -28.67% 19.28% 28.76% -
Other Income 328.12 616.06 433.76 670.99 589.86 258.01 80.65
Total Income 11,261.42 11,261.70 13,226.04 11,958.13 16,413.54 13,524.49 10,383.80
Total Expenses + 8,902.97 8,334.43 11,438.13 9,751.42 11,674.78 10,804.75 7,963.60
Cost of Materials Consumed 5,610.21 5,761.08 7,247.69 5,783.93 7,215.73 6,747.55 4,893.27
Employee Benefit Expense 1,063.07 980.56 1,641.88 1,600.04 1,735.43 1,561.47 1,131.64
Other Expenses 1,704.98 1,592.79 2,548.56 2,367.45 2,723.62 2,495.73 1,938.69
Operating Profit 2,030.33 2,311.21 1,354.15 1,535.72 4,148.90 2,461.73 2,339.55
OPM % 18.6% 21.7% 10.6% 13.6% 26.2% 18.6% 22.7%
Profit Before Exceptional 2,358.45 2,402.92 1,614.35 1,712.19 4,193.01 2,377.70 2,342.94
Exceptional Items 0.00 0.00 0.00 -74.71 0.00 0.00 0.00
Profit Before Tax + 2,358.45 2,402.92 1,614.35 1,637.48 4,193.01 2,377.70 2,342.94
Tax Expense 611.66 448.78 383.94 182.77 1,080.10 504.96 530.17
Tax % 25.9% 18.7% 23.8% 11.2% 25.8% 21.2% 22.6%
Profit After Tax 1,746.79 1,954.14 1,230.41 1,454.71 3,112.91 1,872.74 1,812.77
EPS (Basic) 29.97 33.35 21.00 24.83 53.13 31.96 30.94

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
ASSETS
Non-Current Assets + 19,823.66 17,914.85 15,210.01 0.00 0.00 0.00 0.00
Property, Plant & Equipment 2,185.29 2,222.21 3,481.88 0.00 0.00 0.00 0.00
Capital Work in Progress 87.53 132.68 239.09 0.00 0.00 0.00 0.00
Non-Current Investments 15,209.56 13,393.43 8,221.77 0.00 0.00 0.00 0.00
Goodwill 91.70 91.70 91.70 0.00 0.00 0.00 0.00
Other Intangible Assets 59.81 105.22 113.92 0.00 0.00 0.00 0.00
Current Assets + 7,689.40 7,239.13 9,723.64 0.00 0.00 0.00 0.00
Inventories 2,359.28 2,367.60 4,125.26 0.00 0.00 0.00 0.00
Trade Receivables 4,195.05 3,776.59 4,560.26 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 295.26 83.32 129.65 0.00 0.00 0.00 0.00
Current Investments 0.01 0.01 0.01 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 58.08 58.59 58.59 0.00 0.00 0.00 0.00
Other Equity 20,476.03 19,664.23 17,855.58 0.00 0.00 0.00 0.00
Non-Current Liabilities 558.45 186.42 346.13 0.00 0.00 0.00 0.00
Current Liabilities 6,420.50 5,244.74 6,673.35 0.00 0.00 0.00 0.00
Total Liabilities 6,978.95 5,431.16 7,019.48 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Cash from Operating Activities 1,645.79 1,714.80 1,821.16 3,726.71 0.00 0.00 0.00
Cash from Investing Activities -2,065.90 -159.96 -3,459.68 -1,613.51 0.00 0.00 0.00
Cash from Financing Activities 616.31 -1,837.03 1,719.48 -2,447.54 0.00 0.00 0.00
Net Increase/Decrease in Cash 211.94 -273.81 81.44 -335.37 0.00 0.00 0.00